TB-HAART trial
[...]the authors did not report any tuberculosis drug-susceptibility testing or HIV-resistance testing.
Gespeichert in:
| Veröffentlicht in: | The Lancet infectious diseases 2015, Vol.15 (1), p.14-15 |
|---|---|
| Hauptverfasser: | , |
| Format: | Artikel |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | 15 |
|---|---|
| container_issue | 1 |
| container_start_page | 14 |
| container_title | The Lancet infectious diseases |
| container_volume | 15 |
| creator | Kwong, Jason C Grayson, M Lindsay |
| description | [...]the authors did not report any tuberculosis drug-susceptibility testing or HIV-resistance testing. |
| doi_str_mv | 10.1016/S1473-3099(14)71032-1 |
| format | Article |
| fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1640689139</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>S1473309914710321</els_id><sourcerecordid>3526182981</sourcerecordid><originalsourceid>FETCH-LOGICAL-c443t-c11bb45d973ea6b8801e4c1b3193528090f5e95776eb28821cb8353ebbb7646a3</originalsourceid><addsrcrecordid>eNqFkF1LwzAUQIMobk79B4rgy3yo5jYfbV-UOdQJA0Hnc2jSO8js2plswv696ToV9uJTQjj3JDmEnAG9Bgry5g14wiJGs6wP_CoByuII9kg3HPOIc5Hsb_Yt0iFH3s8ohcDxQ9KJheAAErrkdHIfjQaD18nF0tm8PCYH07z0eLJde-T98WEyHEXjl6fn4WAcGc7ZMjIAWnNRZAnDXOo0pYDcgGaQMRGnNKNTgZlIEok6TtMYjE6ZYKi1TiSXOeuRfutduPpzhX6p5tYbLMu8wnrlFUhOZZoBywJ6uYPO6pWrwusCxWQcuBQCJVrKuNp7h1O1cHaeu7UCqppgahNMNTUUcLUJppq58619pedY_E79FArAXQtgyPFl0SlvLFYGC-vQLFVR23-vuN0xmNJW1uTlB67R__1G-VjRVtI4wtoYgH0DhHaJtw</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1636206881</pqid></control><display><type>article</type><title>TB-HAART trial</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals</source><source>ProQuest Central UK/Ireland</source><creator>Kwong, Jason C ; Grayson, M Lindsay</creator><creatorcontrib>Kwong, Jason C ; Grayson, M Lindsay</creatorcontrib><description>[...]the authors did not report any tuberculosis drug-susceptibility testing or HIV-resistance testing.</description><identifier>ISSN: 1473-3099</identifier><identifier>EISSN: 1474-4457</identifier><identifier>DOI: 10.1016/S1473-3099(14)71032-1</identifier><identifier>PMID: 25541161</identifier><identifier>CODEN: LANCAO</identifier><language>eng</language><publisher>United States: Elsevier Ltd</publisher><subject>Anti-HIV Agents - administration & dosage ; Antiretroviral Therapy, Highly Active - methods ; Female ; HIV ; HIV Infections - drug therapy ; Human immunodeficiency virus ; Humans ; Infectious Disease ; Infectious diseases ; Male ; Mortality ; Tuberculosis ; Tuberculosis, Pulmonary - drug therapy</subject><ispartof>The Lancet infectious diseases, 2015, Vol.15 (1), p.14-15</ispartof><rights>Elsevier Ltd</rights><rights>2015 Elsevier Ltd</rights><rights>Copyright Elsevier Limited Jan 2015</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><cites>FETCH-LOGICAL-c443t-c11bb45d973ea6b8801e4c1b3193528090f5e95776eb28821cb8353ebbb7646a3</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://www.proquest.com/docview/1636206881?pq-origsite=primo$$EHTML$$P50$$Gproquest$$H</linktohtml><link.rule.ids>314,776,780,3536,4009,27902,27903,27904,64361,64363,64365,65309,72215</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25541161$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Kwong, Jason C</creatorcontrib><creatorcontrib>Grayson, M Lindsay</creatorcontrib><title>TB-HAART trial</title><title>The Lancet infectious diseases</title><addtitle>Lancet Infect Dis</addtitle><description>[...]the authors did not report any tuberculosis drug-susceptibility testing or HIV-resistance testing.</description><subject>Anti-HIV Agents - administration & dosage</subject><subject>Antiretroviral Therapy, Highly Active - methods</subject><subject>Female</subject><subject>HIV</subject><subject>HIV Infections - drug therapy</subject><subject>Human immunodeficiency virus</subject><subject>Humans</subject><subject>Infectious Disease</subject><subject>Infectious diseases</subject><subject>Male</subject><subject>Mortality</subject><subject>Tuberculosis</subject><subject>Tuberculosis, Pulmonary - drug therapy</subject><issn>1473-3099</issn><issn>1474-4457</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2015</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><recordid>eNqFkF1LwzAUQIMobk79B4rgy3yo5jYfbV-UOdQJA0Hnc2jSO8js2plswv696ToV9uJTQjj3JDmEnAG9Bgry5g14wiJGs6wP_CoByuII9kg3HPOIc5Hsb_Yt0iFH3s8ohcDxQ9KJheAAErrkdHIfjQaD18nF0tm8PCYH07z0eLJde-T98WEyHEXjl6fn4WAcGc7ZMjIAWnNRZAnDXOo0pYDcgGaQMRGnNKNTgZlIEok6TtMYjE6ZYKi1TiSXOeuRfutduPpzhX6p5tYbLMu8wnrlFUhOZZoBywJ6uYPO6pWrwusCxWQcuBQCJVrKuNp7h1O1cHaeu7UCqppgahNMNTUUcLUJppq58619pedY_E79FArAXQtgyPFl0SlvLFYGC-vQLFVR23-vuN0xmNJW1uTlB67R__1G-VjRVtI4wtoYgH0DhHaJtw</recordid><startdate>2015</startdate><enddate>2015</enddate><creator>Kwong, Jason C</creator><creator>Grayson, M Lindsay</creator><general>Elsevier Ltd</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>0TZ</scope><scope>3V.</scope><scope>7QL</scope><scope>7RV</scope><scope>7U9</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8C1</scope><scope>8C2</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>ABUWG</scope><scope>AEUYN</scope><scope>AFKRA</scope><scope>BENPR</scope><scope>C1K</scope><scope>CCPQU</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>H94</scope><scope>K9.</scope><scope>KB0</scope><scope>M0S</scope><scope>M1P</scope><scope>M7N</scope><scope>NAPCQ</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>7X8</scope></search><sort><creationdate>2015</creationdate><title>TB-HAART trial</title><author>Kwong, Jason C ; Grayson, M Lindsay</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c443t-c11bb45d973ea6b8801e4c1b3193528090f5e95776eb28821cb8353ebbb7646a3</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2015</creationdate><topic>Anti-HIV Agents - administration & dosage</topic><topic>Antiretroviral Therapy, Highly Active - methods</topic><topic>Female</topic><topic>HIV</topic><topic>HIV Infections - drug therapy</topic><topic>Human immunodeficiency virus</topic><topic>Humans</topic><topic>Infectious Disease</topic><topic>Infectious diseases</topic><topic>Male</topic><topic>Mortality</topic><topic>Tuberculosis</topic><topic>Tuberculosis, Pulmonary - drug therapy</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Kwong, Jason C</creatorcontrib><creatorcontrib>Grayson, M Lindsay</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Pharma and Biotech Premium PRO</collection><collection>ProQuest Central (Corporate)</collection><collection>Bacteriology Abstracts (Microbiology B)</collection><collection>Nursing & Allied Health Database</collection><collection>Virology and AIDS Abstracts</collection><collection>Health & Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Public Health Database</collection><collection>Lancet Titles</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest One Sustainability</collection><collection>ProQuest Central UK/Ireland</collection><collection>ProQuest Central</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>Nursing & Allied Health Database (Alumni Edition)</collection><collection>Health & Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Algology Mycology and Protozoology Abstracts (Microbiology C)</collection><collection>Nursing & Allied Health Premium</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>MEDLINE - Academic</collection><jtitle>The Lancet infectious diseases</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Kwong, Jason C</au><au>Grayson, M Lindsay</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>TB-HAART trial</atitle><jtitle>The Lancet infectious diseases</jtitle><addtitle>Lancet Infect Dis</addtitle><date>2015</date><risdate>2015</risdate><volume>15</volume><issue>1</issue><spage>14</spage><epage>15</epage><pages>14-15</pages><issn>1473-3099</issn><eissn>1474-4457</eissn><coden>LANCAO</coden><abstract>[...]the authors did not report any tuberculosis drug-susceptibility testing or HIV-resistance testing.</abstract><cop>United States</cop><pub>Elsevier Ltd</pub><pmid>25541161</pmid><doi>10.1016/S1473-3099(14)71032-1</doi><tpages>2</tpages><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext |
| identifier | ISSN: 1473-3099 |
| ispartof | The Lancet infectious diseases, 2015, Vol.15 (1), p.14-15 |
| issn | 1473-3099 1474-4457 |
| language | eng |
| recordid | cdi_proquest_miscellaneous_1640689139 |
| source | MEDLINE; Elsevier ScienceDirect Journals; ProQuest Central UK/Ireland |
| subjects | Anti-HIV Agents - administration & dosage Antiretroviral Therapy, Highly Active - methods Female HIV HIV Infections - drug therapy Human immunodeficiency virus Humans Infectious Disease Infectious diseases Male Mortality Tuberculosis Tuberculosis, Pulmonary - drug therapy |
| title | TB-HAART trial |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-25T06%3A04%3A08IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=TB-HAART%20trial&rft.jtitle=The%20Lancet%20infectious%20diseases&rft.au=Kwong,%20Jason%20C&rft.date=2015&rft.volume=15&rft.issue=1&rft.spage=14&rft.epage=15&rft.pages=14-15&rft.issn=1473-3099&rft.eissn=1474-4457&rft.coden=LANCAO&rft_id=info:doi/10.1016/S1473-3099(14)71032-1&rft_dat=%3Cproquest_cross%3E3526182981%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1636206881&rft_id=info:pmid/25541161&rft_els_id=S1473309914710321&rfr_iscdi=true |